<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02580734</url>
  </required_header>
  <id_info>
    <org_study_id>BMS2013</org_study_id>
    <nct_id>NCT02580734</nct_id>
  </id_info>
  <brief_title>Efficacy of Melatonin in Burning Mouth Syndrome (BMS)</brief_title>
  <acronym>BMS2013</acronym>
  <official_title>Melatonin to Treat Burning Mouth Syndrome (BMS): A Randomized, Cross-over, Placebo-controlled, Triple-blind Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Milan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether melatonin is effective in the treatment of
      burning mouth syndrome (BMS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a crossover trial involving a total of 20 patients with Burning Mouth Syndrome,
      considered a chronic neuropathic pain. In two consecutive treatment periods, both 8 week
      long, each patient receives externally indistinguishable capsules (placebo or melatonin). A 4
      weeks wash-out period is applied, between these two periods.

      The capsules contain either placebo or 3 mg-melatonin (4 time/day for a total of 12 mg/day of
      melatonin). The primary endpoint is the change in pain intensity at the end of each treatment
      period, measured using VAS, verbal intensity score and NRS, as well as number of oral sites
      affected by the burning sensation. Furthermore, data from quality of life, anxiety and sleep
      questionnaires are collected (sf-36, HAM-A, ESS, MOS).

      Adverse effects are carefully recorded as well as blood samples, in order to measure serum
      melatonin levels during the trial.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction/resolution of symptoms in BMS</measure>
    <time_frame>within the first 60 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>improvement in quality of life</measure>
    <time_frame>within the first 60 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Burning Mouth Syndrome</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>tablet without melatonin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>melatonin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>tablet with melatonin</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>melatonin</intervention_name>
    <description>Cross-over randomized clinical trials</description>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_label>melatonin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients over 18 yrs suffering from burning mouth syndrome

        Exclusion Criteria:

          -  epilepsy

          -  pregnancy

          -  concomitant treatment with melatonin

          -  concomitant anticoagulants

          -  night time working persons
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2013</study_first_submitted>
  <study_first_submitted_qc>October 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2015</study_first_posted>
  <last_update_submitted>October 25, 2015</last_update_submitted>
  <last_update_submitted_qc>October 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Milan</investigator_affiliation>
    <investigator_full_name>ANDREA SARDELLA</investigator_full_name>
    <investigator_title>Associate Professor of Oral Diseases</investigator_title>
  </responsible_party>
  <keyword>burning mouth syndrome</keyword>
  <keyword>treatment</keyword>
  <keyword>oral chronic pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Burns</mesh_term>
    <mesh_term>Burning Mouth Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

